REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Icare Rx (Kota Kinabalu) Sdn. Bhd. (Malaysia)

Main Activities: Pharmacies and Drug Stores
Full name: Icare Rx (Kota Kinabalu) Sdn. Bhd. Profile Updated: February 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Icare Rx (Kota Kinabalu) Sdn. Bhd. is an enterprise in Malaysia, with the main office in Kota Kinabalu. The company operates in the Pharmacies and Drug Stores sector. It was established on December 28, 2018. From the latest financial highlights, Icare Rx (Kota Kinabalu) Sdn. Bhd. reported a net sales revenue increase of 39.41% in 2022. There was a total growth of 52.43% in Icare Rx (Kota Kinabalu) Sdn. Bhd.’s total assets over the same period. In 2022, Icare Rx (Kota Kinabalu) Sdn. Bhd.’s net profit margin increased by 2.43%.

Headquarters
Lot 6-0, Lorong Rampai, Taman Cantek
Kota Kinabalu; Sabah; Postal Code: 88200

Contact Details: Purchase the Icare Rx (Kota Kinabalu) Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Icare Rx (Kota Kinabalu) Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Icare Rx (Kota Kinabalu) Sdn. Bhd. report to view the information.
Incorporation Date:
December 28, 2018
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
64%
Purchase this report to view the information.
36%
Company Performance
Financial values in the chart are available after Icare Rx (Kota Kinabalu) Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
39.41%▲
Total operating revenue
39.41%▲
Operating profit (EBIT)
114.84%▲
Net Profit (Loss) for the Period
115.63%▲
Total assets
52.43%▲
Total equity
76.08%▲
Operating Profit Margin (ROS)
2.92%▲
Net Profit Margin
2.43%▲
Return on Equity (ROE)
11.91%▲
Quick Ratio
0.1%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo